Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Sells $58,542.48 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 108 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Jamie Samath also recently made the following trade(s):

• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00.
• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41.

Intuitive Surgical Trading Down 0.7 %

NASDAQ ISRG opened at $538.55 on Friday. The firm has a market cap of $191.82 billion, a price-to-earnings ratio of 86.58, a PEG ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $552.00. The company has a 50 day moving average of $508.91 and a 200-day moving average of $467.29.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analysts Set New Price Targets

ISRG has been the subject of several research analyst reports. Raymond James boosted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $526.06.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Peapack Gladstone Financial Corp raised its stake in shares of Intuitive Surgical by 1.3% in the third quarter. Peapack Gladstone Financial Corp now owns 13,085 shares of the medical equipment provider’s stock worth $6,427,000 after acquiring an additional 167 shares during the last quarter. Synovus Financial Corp increased its holdings in shares of Intuitive Surgical by 1.1% in the third quarter. Synovus Financial Corp now owns 2,572 shares of the medical equipment provider’s stock valued at $1,264,000 after purchasing an additional 28 shares in the last quarter. Destination Wealth Management raised its position in Intuitive Surgical by 4.1% in the 3rd quarter. Destination Wealth Management now owns 770 shares of the medical equipment provider’s stock worth $378,000 after purchasing an additional 30 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares in the last quarter. Finally, Arvest Bank Trust Division bought a new position in Intuitive Surgical in the 3rd quarter valued at $260,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.